Adenovirus type 4 a
Ended Awarded Last action
- Contract number
- SPE2DP26F5471
- Awardee
-
Teva Pharmaceuticals Usa, Inc. UEI NEN9A34LRHJ5
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $515,290
Award facts
- Contract value 100% obligated
- $515,289.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Parsippany, NJ 07054, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency's Medical Supply Chain issued a $515,289.60 delivery order to Teva Pharmaceuticals Usa, Inc. on May 11, 2026, for Adenovirus Type 4 vaccine, with ultimate completion by May 19, 2026.
This order is issued under the Indefinite Delivery Contract SPE2DP20D0002, the primary vehicle through which DLA Troop Support Medical procures Adenovirus Type 4 vaccine for Department of Defense immunization programs. Place of performance is Parsippany, New Jersey. The order is priced on a firm-fixed-price basis with no set-aside.
Quick answers
Who was awarded contract SPE2DP26F5471?
SPE2DP26F5471 was awarded to Teva Pharmaceuticals Usa, Inc. by Medical Supply Chain (Troop Support) on May 11, 2026.
How much is contract SPE2DP26F5471 worth?
The government has obligated $515,290 on SPE2DP26F5471.
Is contract SPE2DP26F5471 an order under another contract?
Yes. SPE2DP26F5471 is a delivery order under SPE2DP20D0002, an indefinite delivery contract.
Was contract SPE2DP26F5471 competed?
The extent of competition for SPE2DP26F5471 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award